Balchem Corporation (BCPC)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 108,543 103,301 99,475 99,147 105,367 108,910 108,674 101,623 96,104 93,317 89,872 88,266 84,623 82,844 81,952 80,656 79,671 79,622 78,160 78,010
Total stockholders’ equity US$ in thousands 1,053,980 1,025,270 1,006,900 973,416 938,284 895,922 901,370 873,682 877,015 889,078 869,642 849,492 828,233 819,443 792,523 766,271 743,667 733,586 732,345 710,509
ROE 10.30% 10.08% 9.88% 10.19% 11.23% 12.16% 12.06% 11.63% 10.96% 10.50% 10.33% 10.39% 10.22% 10.11% 10.34% 10.53% 10.71% 10.85% 10.67% 10.98%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $108,543K ÷ $1,053,980K
= 10.30%

Balchem Corp.'s return on equity (ROE) has shown a gradual decline over the past few quarters, starting at 11.63% in Q1 2022 and dropping to 10.30% in Q4 2023. This indicates a decreasing trend in the company's ability to generate profits from shareholders' equity.

While the ROE figures have fluctuated slightly between 9.88% and 12.16% during this period, the overall trend suggests a slight decrease in profitability relative to the equity investment in the company. A declining ROE could be a concern for investors, as it may indicate inefficiencies in the utilization of company resources or challenges in generating sustainable returns on equity.

It is important for Balchem Corp. to closely monitor and address the factors contributing to the decline in ROE, such as increasing expenses, declining revenues, or deteriorating asset quality. Management should consider strategic initiatives to improve operational efficiency, enhance profitability, and ultimately boost the company's return on equity to create value for its shareholders.


Peer comparison

Dec 31, 2023